Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://fedibird.com/users/upasampada/statuses/109563216677119902">衆善奉行 (upasampada@fedibird.com)'s status on Friday, 23-Dec-2022 23:13:24 JST</a><a href="https://fedibird.com/@upasampada" title="upasampada@fedibird.com"><img src="https://gnusocial.jp/avatar/32176-48-20221130084042.webp" width="48" height="48" alt="衆善奉行" style="position: absolute; left: 0; top: 0;">衆善奉行</a><div><a href="https://fedibird.com/@upasampada/109563211199899034" rel="in-reply-to">in reply to</a></div></section><article><p>改めて考えてみると何言ってるのかよくわからなかったので軽くググってみたところ</p><p>オミクロン株対応ワクチン、従来型を上回る効果見られず－調査<br><a href="https://www.bloomberg.co.jp/news/articles/2022-10-26/RKC2C6DWLU6801" rel="nofollow noreferrer">https://www.bloomberg.co.jp/news/articles/2022-10-26/RKC2C6DWLU6801</a></p><p>という記事が出てきて、まあこれも10月の発表なので最新のはどうなのか、とみてみると、</p><p><a href="https://www.yalemedicine.org/news/omicron-booster-covid-19" rel="nofollow noreferrer">https://www.yalemedicine.org/news/omicron-booster-covid-19</a></p><p>”In mid-December, the CDC put out new data from two studies that suggest the bivalent boosters offer significant protection against illness and hospitalization”</p><p>とは書いているので一応の効果はあるのでしょうが。</p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/909800#notice-2093638">In conversation</a><time datetime="2022-12-23T23:13:24+09:00" title="Friday, 23-Dec-2022 23:13:24 JST">Friday, 23-Dec-2022 23:13:24 JST</time> <span>from <span><a href="https://fedibird.com/@upasampada/109563216677119902" rel="external" title="Sent from fedibird.com via ActivityPub">fedibird.com</a></span></span><a href="https://fedibird.com/@upasampada/109563216677119902">permalink</a><h4>Attachments</h4><ol><li><label><a rel="external" href="https://gnusocial.jp/attachment/526301">Untitled attachment</a></label><br></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
衆善奉行 (upasampada@fedibird.com)'s status on Friday, 23-Dec-2022 23:13:24 JST 衆善奉行
in reply to
改めて考えてみると何言ってるのかよくわからなかったので軽くググってみたところ
オミクロン株対応ワクチン、従来型を上回る効果見られず－調査
https://www.bloomberg.co.jp/news/articles/2022-10-26/RKC2C6DWLU6801
という記事が出てきて、まあこれも10月の発表なので最新のはどうなのか、とみてみると、
https://www.yalemedicine.org/news/omicron-booster-covid-19
”In mid-December, the CDC put out new data from two studies that suggest the bivalent boosters offer significant protection against illness and hospitalization”
とは書いているので一応の効果はあるのでしょうが。
In conversationFriday, 23-Dec-2022 23:13:24 JST from fedibird.compermalink
Attachments
1. Untitled attachment

Public

Embed Notice

HTML Code

Corresponding Notice